SAN DIEGO — Bioimpedance spectrometry (BIS) is more faithful and sure than another methods of subclinical categorization of lymphedema in boob cancer patients, according to a essay publicised in the July 20 supply of Journal of Clinical Oncology (2008; Vol. 26, Issue 21: 3536- 3542). Titled “Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function,” the paper, authored by Sandra Hayes, PhD., and colleagues from Queensland University of Technology in Australia, is supported on a think that participating 265 boob cancer patients. Approximately 87 proportionality of the patients had undergone lymph convexity dissection, 70 proportionality had conventional irradiation therapy and 40 proportionality had conventional chemotherapy and/or h…

Tags: Breast, breast cancer, Cancer, chemotherapy, Clinical Assessment, Colleagues, Led, Phd, Risk, San Diego